Author

V. Nakaar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Almassian· 2 shared T. O. Yarovinsky· 2 shared A. B. Alvero· 1 shared A. Chattopadhyay Pal· 1 shared A. Fox· 1 shared B. Madina· 1 shared B. R. Madina· 1 shared C. Chiale· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. Almassian

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory

A. B. Alvero, A. Fox, B. Madina, M. Krady, R. Gogoi, H. Chehade, V. Nakaar, B. Almassian, T. O. Yarovinsky, T. Rutherford, G. Mor

This paper develops CARG-2020, a virus-like-vesicle that modulates immune responses to enhance anti-tumor immunity and establish immunological memory in ovarian cancer.

bioRxiv · Sep 27, 2023Immunology

Virus-like vesicles expressing multiple antigens for immunotherapy of chronic hepatitis B

T. O. Yarovinsky, S. W. Mason, M. Menon, M. M. Krady, M. Haslip, B. R. Madina, X. Ma, S. Moshkani, C. Chiale, A. Chattopadhyay Pal, B. Almassian, J. K. Rose, M. D. Robek, V. Nakaar

This paper develops virus-like vesicles (VLV) expressing multiple HBV antigens for immunotherapy of chronic hepatitis B, showing 40% efficacy in a mouse model.

bioRxiv · Feb 19, 2019Immunology